US Patent Issued for BCM-95 Curcumin for Alzheimer's
BENGALURU, India, Dec. 1, 2014 /PRNewswire/ -- BCM-95 Curcumin, the patented turmeric extract formulation from Arjuna Natural Extracts Ltd., has received a US patent (US Patent No. 8859020) for its use as a potential treatment for Alzheimer's disease. The patent describes the unique combination of beneficial curcuminoids and turmeric essential oil in BCM-95, as well as its enhanced absorption and bioavailability.
BCM-95 Curcumin has already undergone human clinical trials in patients with Alzheimer's disease at Chinese University of Hong Kong under Professor Larry Baum (2008). It was found to be highly beneficial in preventing further cognitive decline, reducing amyloid beta plaques, one of the major causes of Alzheimer's disease; increasing vitamin E levels in the body; and enhancing curcumin levels in blood. Under the pioneering researcher Professor Ralph Martins in Australia, BCM-95 Curcumin is also undergoing two other human clinical trials in patients with Alzheimer's disease and in subjects at risk of developing Alzheimer's disease.
"These research findings will open a new world of hope to the millions battling Alzheimer's every day, as they will now have a natural and safe alternative for addressing Alzheimer's," says Dr. Benny Antony (Inventor of BCM-95), Joint Managing Director, Arjuna Natural Extracts Ltd.
BCM-95 Curcumin research has been published in more than 23 peer-reviewed publications. It has 12 granted and 15 ongoing patents in India, US and Japan and more patents pending worldwide. BCM-95 Curcumin is also being studied for various indications including inflammation, arthritis, diabetes, depression, cancer prevention and treatment, as an adjuvant to chemotherapy and cancer radiation, liver and gastrointestinal diseases and more.
Arjuna Natural Extracts Ltd. is India's leading company specializing in scientific methods of identification, separation and manufacturing of plant-based active compounds and Omega-3 fatty acids from marine and vegetable source. The company, based in Kerala, India, has been recognized for its dedication to research and innovation, winning several national awards from government bodies.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-patent-issued-for-bcm-95-curcumin-for-alzheimers-300001700.html
SOURCE Arjuna Natural Extracts Ltd.
Share this article